PremiumPre-EarningsASMB Earnings this Week: How Will it Perform? Assembly Biosciences doses first participant in Phase 1a study of ABI-6250 Assembly Biosciences reports positive Phase 1a results in genital herpes PremiumThe FlyAssembly Biosciences reports Q3 EPS ($1.51), consensus ($2.02) Is ASMB a Buy, Before Earnings? Assembly Biosciences reports interim Phase 1a results from trial of ABI-5366 PremiumPre-EarningsASMB Earnings this Week: How Will it Perform? Assembly Biosciences presents preclinical data of investigational HSV portfoli Assembly Biosciences doses first participant in Phase 1b trial of ABI-4334 
